A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ESBL

Search Conditions:
Search Keyword : ESBL
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: ESBL
Appearance Frequency: 5169 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
extended-spectrum beta-lactamase
(5127 times)
Microbiology
(1335 times)
MDR (408 times)
MRSA (280 times)
PFGE (229 times)
1992 Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime.
extended beta-lactamase
(8 times)
Medicine
(2 times)
CF (1 time)
DAEC (1 time)
DD (1 time)
2007 Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period.
ESBL and AmpC-beta-lactamase
(3 times)
Communicable Diseases
(1 time)
ESBL-PE (2 times)
OPD (1 time)
2020 Carriage of Extended-Spectrum-beta-Lactamase- and AmpC-beta-Lactamase-Producing Enterobacteriaceae (ESBL-PE) in Healthy Community and Outpatient Department (OPD) Patients in Nepal.
exo-small beta-lactamase
(2 times)
Biochemistry
(1 time)
--- 2007 Effects of serine-to-cysteine mutations on beta-lactamase folding.
extended spectrum beta-lactamase-producing gram-negative pathogens
(2 times)
Rehabilitation
(2 times)
MRSA (3 times)
MDRO (2 times)
2015 [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main-District, Germany, 2014: Prevalence and Risk Factors].
Extended-Spectrum Beta-Lactamase producing E.coli
(2 times)
Communicable Diseases
(2 times)
MRSA (1 time)
Mtb (1 time)
UVC (1 time)
2016 Reversal of resistance in bacteria underlies synergistic effect of essential oils with conventional antibiotics.
extended-spectrum beta-lactamase-producing organisms
(2 times)
Communicable Diseases
(1 time)
CI (1 time)
CRE (1 time)
LTACs (1 time)
2010 Recognition and management of extended spectrum beta lactamase producing organisms (ESBL).
Extended-Spectrum BLs
(2 times)
Anti-Bacterial Agents
(1 time)
BLI (2 times)
BLs (2 times)
BA (1 time)
2017 Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-beta-lactamases.
CTX-M-type-extended-spectrum beta-lactamase
(1 time)
Microbiology
(1 time)
PFGE (1 time)
2020 Characterization of CTX-M-type-extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from Indonesian undergraduate medical students of a university in Surabaya, Indonesia.
10  encoding clinically important carbapenemases as well as selected extended
(1 time)
Science
(1 time)
--- 2014 Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assay.
11  Enterobacterales strains resistant to this group of anti-bacterial drugs
(1 time)
Biochemistry
(1 time)
--- 2021 Escherichia coli and Serratia fonticola ESBLs as a potential source of antibiotics resistance dissemination in the Tricity water reservoirs.
12  enterobacteria produced by beta lactamase were recorded
(1 time)
General Surgery
(1 time)
CDC (1 time)
CNS (1 time)
NI (1 time)
2009 [Results of epidemiological surveillance of hospital infections at the Clinic of Digestive System Surgery, CCS, in 2007].
13  ESBL producer with identical bla
(1 time)
Communicable Diseases
(1 time)
--- 2012 Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting.
14  ESBL, except when bla
(1 time)
Drug Therapy
(1 time)
TEM (1 time)
2005 Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain.
15  ESBL-producing, fosfomycin-resistant E. coli. bla
(1 time)
Drug Therapy
(1 time)
ESBLs (1 time)
2009 CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
16  ESBLs and by sequencing of bla
(1 time)
Medicine
(1 time)
PFGE (1 time)
UPEC (1 time)
2012 Characterization of the extended-spectrum β-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children.
17  ESBLs were characterized by PCR and sequencing of bla
(1 time)
Drug Therapy
(1 time)
PFGE (1 time)
2010 Emergence of Proteus mirabilis isolates producing TEM-52 extended-spectrum beta-lactamases in Croatia.
18  especiallyextended-spectrum beta-lactamase
(1 time)
CA-UTI (1 time)
CLSI, USA (1 time)
MALDI-TOF (1 time)
2021 Increased Isolation of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli From Community-Onset Urinary Tract Infection Cases in Uttarakhand, India.
19  established by PFGE and multilocus sequence typing (MLST). bla
(1 time)
Drug Therapy
(1 time)
MLST (1 time)
2009 Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults.
20  ester of CBL
(1 time)
Neoplasms
(1 time)
BC (1 time)
CBL (1 time)
ERalpha (1 time)
2006 The effect of an estrone D-lactam steroid ester derivative on breast cancer cells and its predicted binding interactions with the ligand binding domain of estrogen receptor-alpha.
21  EUCAST guidelines were followed for antibiotic susceptibility testing, and bla
(1 time)
Drug Therapy
(1 time)
ESBL-EC (1 time)
UTIs (1 time)
2010 Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.
22  Extended spectrum beta lactamase forming pathogens
(1 time)
Medicine
(1 time)
--- 2012 [Extended spectrum beta lactamase forming pathogens (ESBL)].
23  extended-spectrum beta-lactamase Escherichia coli
(1 time)
Endoscopy, Digestive System
(1 time)
ERCP (1 time)
2014 Fatal Cerebral Air Embolism Due to a Patent Foramen Ovale during Endoscopic Retrograde Cholangiopancreatography.
24  extended-spectrum beta-lactamase-producing Klebsiella pneumoniae
(1 time)
Drug Therapy
(1 time)
--- 2008 Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
25  extended-spectrum producing beta-lactamase
(1 time)
Hospitals
(1 time)
PICU (1 time)
2010 Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit.
26  plasmid-coded broad-spectrum Beta-lactamases
(1 time)
Microbiology
(1 time)
OMP (1 time)
2006 [Development of Beta-lactamase resistance in enterobacteria].
27  plasmid-mediated-extended-spectrum-beta-lactamase
(1 time)
Communicable Diseases
(1 time)
--- 2003 Plasmid-mediated extended-spectrum beta-lactamase-producing strains of Enterobacteriaceae isolated from diabetes foot infections in a Brazilian diabetic center.
28  pneumoniae Extended Spectrum beta-Lactamase
(1 time)
Biochemical Phenomena
(1 time)
HSV-2 (1 time)
SARS-CoV-2 (1 time)
ZIKV (1 time)
2021 Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial Strains.
29  well-established methods for screening and confirmation of class A
(1 time)
Microbiology
(1 time)
3-APB (1 time)
BA (1 time)
M3DT (1 time)
2012 [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].